Research Report Identifies National General, Eidos Therapeutics, Auris Medical Holding AG, and Realogy with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of National General Holdings Corp (NASDAQ:NGHC), Eidos Therapeutics, Inc. (NASDAQ:EIDX), Auris Medical Holding AG (NASDAQ:EARS), and Realogy Holdings Corp. (NYSE:RLGY), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

NGHC DOWNLOAD: http://Fundamental-Markets.com/register/?so=NGHC
EIDX DOWNLOAD: http://Fundamental-Markets.com/register/?so=EIDX
EARS DOWNLOAD: http://Fundamental-Markets.com/register/?so=EARS
RLGY DOWNLOAD: http://Fundamental-Markets.com/register/?so=RLGY

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine National General Holdings Corp (NASDAQ:NGHC), Eidos Therapeutics, Inc. (NASDAQ:EIDX), Auris Medical Holding AG (NASDAQ:EARS), and Realogy Holdings Corp. (NYSE:RLGY) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

NATIONAL GENERAL HOLDINGS CORP (NGHC) REPORT OVERVIEW

National General's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, National General reported revenue of $1,186.77MM vs $1,066.74MM (up 11.25%) and analysts estimated basic earnings per share $0.15 vs -$0.09. For the twelve months ended December 31st, 2018 vs December 31st, 2017, National General reported revenue of $4,607.97MM vs $4,422.07MM (up 4.20%) and analysts estimated basic earnings per share $1.62 vs $0.70 (up 131.43%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $2.98 and is expected to report on February 24th, 2020.

To read the full National General Holdings Corp (NGHC) report, download it here: http://Fundamental-Markets.com/register/?so=NGHC

-----------------------------------------

EIDOS THERAPEUTICS, INC. (EIDX) REPORT OVERVIEW

Eidos Therapeutics' Recent Financial Performance

Analysts expect earnings to be released on July 15th, 2019. The report will be for the fiscal period ending March 31st, 2019. The estimated EPS forecast for the next fiscal year is -$1.95 and is expected to report on April 20th, 2020.

To read the full Eidos Therapeutics, Inc. (EIDX) report, download it here: http://Fundamental-Markets.com/register/?so=EIDX

-----------------------------------------

AURIS MEDICAL HOLDING AG (EARS) REPORT OVERVIEW

Auris Medical Holding AG's Recent Financial Performance

Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.32. The estimated EPS forecast for the next fiscal year is -$0.84 and is expected to report on March 12th, 2020.

To read the full Auris Medical Holding AG (EARS) report, download it here: http://Fundamental-Markets.com/register/?so=EARS

-----------------------------------------

REALOGY HOLDINGS CORP. (RLGY) REPORT OVERVIEW

Realogy's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Realogy reported revenue of $1,354.00MM vs $1,444.00MM (down 6.23%) and basic earnings per share -$0.20 vs $1.86. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Realogy reported revenue of $6,079.00MM vs $6,114.00MM (down 0.57%) and analysts estimated basic earnings per share $1.10 vs $3.15 (down 65.08%). Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.38. The estimated EPS forecast for the next fiscal year is $1.42 and is expected to report on February 25th, 2020.

To read the full Realogy Holdings Corp. (RLGY) report, download it here: http://Fundamental-Markets.com/register/?so=RLGY

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Arden Dalio, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.